Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 8Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 8Pancreatic Neoplasms 4Rectal Neoplasms 3Colonic Neoplasms 2Stomach Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Esophageal Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Irinotecan × Clear all
NCT01939483 2014-10-08

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

University of California, Irvine

Phase NA Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡